Abstracts

HIGH-DOSE RIFAMPICIN FOR THE TREATMENT OF LEPROSY IN HIV PATIENTS TAKING DOLUTEGRAVIR

High dose rifampicin is being investigated for shortening TB therapy as well as in other indications such as leprosy. Strategies to manage the risk of drug-drug interactions (DDIs) with co-administered antiretroviral drugs may therefore be needed. The current study used physiologically-based pharmacokinetic (PBPK) modelling to predict the magnitude of DDI between once monthly (QMT) high…

LONG-TERM ADHERENCE MONITORING OF EMTRICITABINE IN HAIR BY MASS SPECTROMETRY IMAGING

Adherence to antiretroviral therapy is critical for effective treatment and prevention of HIV. Incorporation of drug in hair creates a long-term record of adherence behavior, and mass spectrometry imaging (MSI) using infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI) offers a means of monitoring changes in this record as an objective measure of adherence. Here we…

COMPARING TFV-DP & FTC-TP IN PBMC, RBC, NEUTROPHILS, & PLATELETS WITH F/TDF VS F/TAF

Emtricitabine (FTC) plus tenofovir alafenamide (F-TAF) or tenofovir disoproxil (F-TDF) undergo cell-specific conversion, resulting in differential pharmacokinetics (PK) of tenofovir-diphosphate (TFV-DP) and FTC-triphosphate (FTC-TP) across cell types. The selective cleavage of TAF via cathepsin A allows for more targeted delivery of TFV to cell types expressing that enzyme, such as peripheral blood mononuclear cells (PBMC).…

USE OF D/C/F/TAF WITH NEUROLOGIC/PSYCHIATRIC COMORBIDITIES: AMBER SUBGROUP ANALYSIS

Patients with human immunodeficiency virus (HIV)–1 and neurologic or psychiatric comorbidities (NPCs) may face challenges with HIV-1 care. The phase 3 AMBER trial (ClinicalTrials.gov: NCT02431247) enrolled treatment-naïve, HIV-1–infected adults who were randomized 1:1 to receive once-daily darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) 800/150/200/10mg or control (D/C+F/tenofovir disoproxil fumarate). Here we report a subgroup analysis evaluating efficacy/safety in those…